Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/9952| Title: | CNTO-328 (Centocor). | Austin Authors: | Li, Jie;Hu, Xiu Feng;Xing, Pei Xiang | Affiliation: | The Austin Research Institute, Kronheimer Building, Austin Health, Studley Road, Heidelberg 3084, Victoria, Australia | Issue Date: | 1-Jun-2005 | Publication information: | Current Opinion in Investigational Drugs (london, England : 2000); 6(6): 639-45 | Gov't Doc #: | 15988916 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/9952 | Journal: | Current opinion in investigational drugs (London, England : 2000) | URL: | https://pubmed.ncbi.nlm.nih.gov/15988916 | Type: | Journal Article | Subjects: | Animals Antibodies, Monoclonal.adverse effects.pharmacokinetics.therapeutic use Antineoplastic Agents.adverse effects.pharmacokinetics.therapeutic use Clinical Trials as Topic Humans Interleukin-6.immunology Neoplasms.drug therapy.metabolism |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.